354 Preventing the cleavage of the TGFβ type I receptor by presenilin 1 could limit prostate tumor growth.
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;7/307/ra2
353 Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma.
http://www.sciencemag.org/content/343/6167/189.abstract
352 microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition.
http://www.nature.com/ncomms/2014/140107/ncomms3977/full/ncomms3977.html
351 Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.
http://www.nature.com/neuro/journal/v17/n1/abs/nn.3597.html
350 Inactivating CUX1 mutations promote tumorigenesis.
http://www.nature.com/ng/journal/v46/n1/abs/ng.2846.html
349 Self-renewal as a therapeutic target in human colorectal cancer.
http://www.nature.com/nm/journal/v20/n1/abs/nm.3418.html
348 Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression.
http://stm.sciencemag.org/content/6/217/217ra3.abstract
347 Silencing HoxA1 by Intraductal Injection of siRNA Lipidoid Nanoparticles Prevents Mammary Tumor Progression in Mice.
http://stm.sciencemag.org/content/6/217/217ra2.abstract
346 Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program.
http://www.cell.com/abstract/S0092-8674(13)01480-3
345 Mutant KRAS is a druggable target for pancreatic cancer.
http://www.pnas.org/content/110/51/20723.abstract
344 CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis.
http://www.pnas.org/content/110/51/20717.abstract
343 Ascites analysis by a microfluidic chip allows tumor-cell profiling.
http://www.pnas.org/content/110/51/E4978.abstract
342 p53 status determines the role of autophagy in pancreatic tumour development.
http://www.nature.com/nature/journal/v504/n7479/full/nature12865.html
341 Niche-based screening identifies small-molecule inhibitors of leukemia stem cells.
http://www.nature.com/nchembio/journal/v9/n12/abs/nchembio.1367.html
340 Preventing the methylation of VEGFR-2 could attenuate pathological angiogenesis in cancer.
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;6/304/ra104
339 Targeting signaling pathways upstream of oncogenic Ras may have therapeutic benefit in the treatment of leukemia.
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;6/304/ra105
338 A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.
http://www.nature.com/nature/journal/v504/n7478/full/nature12688.html
337 The activity of a specific metabolite of cholesterol may help explain why obesity is a risk factor for breast cancer.
http://www.sciencemag.org/content/342/6162/1094.abstract
336 Bioavailable copper modulates oxidative phosphorylation and growth of tumors.
http://www.pnas.org/content/110/48/19507.abstract
335 The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide.
http://www.sciencemag.org/content/342/6161/971.abstract
|
